Search

Kevin J Roberg-Perez

from Minneapolis, MN
Age ~59
Get Report
Also known as:
Kevin J Roberg, Kevin James Roberg-Perez, Kevin Roberg Perez, Kevin James Roberg, Kevin J Perez, Kevin Z, Perez Kevin Roberg, Perez Roberg
Phone and address:
2250 Cleveland St, Minneapolis, MN 55418
(612) 788-4420
Related to:
John Rohner
Connected to:
Elizabeth D Roberg, 43Greg R Roberg, 69Heather Roberg, 50Jane B Roberg, 49Aaron M Roberge, 34Angela L Roberge, 59Bridget B Roberge, 52Chantal A Roberge, 53Christian L Roberge, 28Colette Roberge, 50

Kevin Roberg-Perez Phones & Addresses

  • 2250 Cleveland St, Minneapolis, MN 55418 (612) 788-4420
  • Muscatine, IA
  • Beverly, MA
  • Wayzata, MN
  • Pasadena, CA
  • Saint Paul, MN
  • Somerville, MA

Work

Company: R&d systems Jun 2007 to Jan 2013 Position: Principal bioinformatician

Education

School / High School: Caltech 1997 to 1998

Skills

Bioinformatics • Genomics • Molecular Biology • Genetics • Life Sciences • Biochemistry • Sequence Analysis • Sequencing • Perl • Cell • Lifesciences • Data Analysis • Databases • R&D • Microarray • Lims • Microarray Analysis • Linux • Ruby on Rails • Informatics • Mysql • Ruby • Agile Project Management • Database Development • Cell Biology • Research and Development

Languages

Italian

Industries

Biotechnology

Resumes

Resumes

Kevin Roberg-Perez Photo 1

Founder

View page
Location:
Minneapolis, MN
Industry:
Biotechnology
Work:
R&D Systems Jun 2007 - Jan 2013
Principal Bioinformatician
Bioi Jun 2007 - Jan 2013
Founder
Natureworks 2003 - 2007
Senior Bioinformatician
Masonic Cancer Center, University of Minnesota 2001 - 2003
Bioinformatics Scientist
Proteome 1998 - 2001
Senior Manager, Database Development
Education:
Caltech 1997 - 1998
Massachusetts Institute of Technology 1990 - 1997
Massachusetts Institute of Technology 1972 - 1974
University of Minnesota
Bachelors, Bachelor of Arts, Italian University of Minnesota
Bachelors, Bachelor of Science, Genetics, Biology
Skills:
Bioinformatics
Genomics
Molecular Biology
Genetics
Life Sciences
Biochemistry
Sequence Analysis
Sequencing
Perl
Cell
Lifesciences
Data Analysis
Databases
R&D
Microarray
Lims
Microarray Analysis
Linux
Ruby on Rails
Informatics
Mysql
Ruby
Agile Project Management
Database Development
Cell Biology
Research and Development
Languages:
Italian

Publications

Us Patents

Yeast Cells Having Disrupted Pathway From Dihydroxyacetone Phosphate To Glycerol

View page
US Patent:
20090053782, Feb 26, 2009
Filed:
Mar 13, 2007
Appl. No.:
12/281286
Inventors:
Catherine Asleson Dundon - Minneapolis MN, US
Pirkko Suominen - Maple Grove MN, US
Aristos Aristidou - Highland Ranch CO, US
Brian J. Rush - Minneapolis MN, US
Kari Koivuranta - Helsinki, FI
Benjamin Matthew Hause - Currie MN, US
Thomas William McMullin - Minnetonka MN, US
Kevin Roberg-Perez - Minneapolis MN, US
International Classification:
C12P 7/56
C12N 1/19
US Classification:
435139, 4352551, 4352542, 43525421
Abstract:
Yeast cells are genetically modified to disrupt a native metabolic pathway from dihydroxyacetone to glycerol. In certain aspects, the yeast cell is of the genera or . In other aspects, the yeast cell is capable of producing at least one organic acid, such as lactate. The yeast cells produce significantly less glycerol than the wild-type strains, and usually produce greater yields of desired fermentation products. Yeast cells of the invention often grow well when cultivated, despite their curtailed glycerol production.

Genetically Modified Yeast Of The Species Issatchenkia Orientalis And Closely Relates Species, And Fermentation Processes Using Same

View page
US Patent:
20090226989, Sep 10, 2009
Filed:
May 30, 2006
Appl. No.:
11/921161
Inventors:
Pirkko Suominen - Maple Grove MN, US
Aristos Aristidou - Maple Grove MN, US
Merja Penttila - Helsinki, FI
Marja Ilmen - Helsinki, FI
Laura Ruohonen - Helsinki, FI
Kari Koivuranta - Helsinki, FI
Kevin Roberg-Perez - Minneapolis MN, US
International Classification:
C12P 7/56
C12N 1/19
C12N 15/63
US Classification:
435139, 4352542, 4353201
Abstract:
Cells of the species and closely related yeast species are transformed with a vector to introduce an exogenous lactate dehydrogenase gene. The cells produce lactic acid efficiently and are resistant at low pH, high lactate titer conditions.

Genetically Modified Yeast Of The Species Issatchenkia Orientalis And Closely Related Species, And Fermentation Processes Using Same

View page
US Patent:
20120129230, May 24, 2012
Filed:
Dec 9, 2011
Appl. No.:
13/316044
Inventors:
Pirkko Suominen - Maple Grove MN, US
Aristos Aristidou - Highland Ranch CO, US
Merja Penttila - Helsinki, FI
Marja Ilmen - Helsinki, FI
Laura Ruohonen - Helsinki, FI
Kari Koivuranta - Vantaa, FI
Kevin Roberg-Perez - Minneapolis MN, US
International Classification:
C12P 7/56
C12P 17/06
C12P 7/62
C12N 1/19
US Classification:
435125, 4352542, 43525423, 43525422, 435139, 435135
Abstract:
Cells of the species and closely related yeast species are transformed with a vector to introduce an exogenous lactate dehydrogenase gene. The cells produce lactic acid efficiently and are resistant at low pH, high lactate titer conditions.

Synthesis Of Beta-Hydroxyisovalerate And Methods Of Use

View page
US Patent:
20220325304, Oct 13, 2022
Filed:
Apr 6, 2022
Appl. No.:
17/658214
Inventors:
- St. Paul MN, US
Christopher Lindsay - St. Paul MN, US
Kevin Roberg-Perez - Minneapolis MN, US
Christopher D. Snow - St. Paul MN, US
Elizabeth A. Cameron - New Brighton MN, US
International Classification:
C12P 7/16
C12N 9/88
C12N 9/04
C12N 15/52
Abstract:
The biological production of beta-hydroxyisovalerate (βHIV) using at least one non-natural enzyme. The non-natural enzyme for the biologically-derived βHIV provides more beta-hydroxyisovalerate synthase activity than the wild-type parent. The non-natural enzyme having one or more modifications of substrate-specificity positions. The non-natural enzyme can be expressed in a microorganism, such as a yeast or bacteria, wherein the microorganism comprises an active βHIV metabolic pathway for the production of βHIV. Alternatively, the non-natural enzyme can be a βHIV synthase used to produce βHIV in a cell-free environment. The biological derivation of βHIV eliminates toxic by-products and impurities that result from the chemical production of βHIV, such that βHIV produced by a non-natural enzyme prior to any isolation or purification process has not been in substantial contact with any halogen-containing component.

Synthesis Of Beta-Hydroxyisovalerate And Methods Of Use

View page
US Patent:
20220315954, Oct 6, 2022
Filed:
Apr 6, 2022
Appl. No.:
17/658217
Inventors:
- St. Paul MN, US
Christopher Lindsay - St. Paul MN, US
Kevin Roberg-Perez - Minneapolis MN, US
Christopher D. Snow - St. Paul MN, US
Elizabeth A. Cameron - New Brighton MN, US
International Classification:
C12P 7/16
C12N 9/04
C12N 1/20
Abstract:
The biological production of beta-hydroxyisovalerate (βHIV) using a non-natural microorganism. The non-natural microorganism for the biologically-derived βHIV provides more beta-hydroxyisovalerate synthase activity than the wild-type parent. The non-natural microorganism can host a non-natural enzyme, such as the non-natural enzyme expressed in a yeast or bacteria, wherein the non-natural microorganism comprises an active βHIV metabolic pathway for the production of βHIV. The biological derivation of βHIV eliminates toxic by-products and impurities that result from the chemical production of βHIV, such that βHIV produced by a non-natural microorganism prior to any isolation or purification process has not been in substantial contact with any halogen-containing component.

Yeast Cells Having Disrupted Pathway From Dihydroxyacetone Phosphate To Glycerol

View page
US Patent:
20210155411, May 27, 2021
Filed:
Jan 21, 2021
Appl. No.:
17/154190
Inventors:
- Wayzata MN, US
Pirrko Suominen - Maple Grove MN, US
Aristos Aristidou - Excelsior MN, US
Brian J. Rush - Minneapolis MN, US
Kari Koivuranta - Helsinki, FI
Benjamin Matthew Hause - Currie MN, US
Thomas William McMullin - Minnetonka MN, US
Kevin Roberg-Perez - Minneapolis MN, US
Assignee:
Cargill, Incorporated - Wayzata MN
International Classification:
B65G 15/12
C12P 7/06
C12P 7/40
C12N 15/52
C12P 7/56
B65G 17/12
E01B 29/32
Abstract:
Yeast cells are genetically modified to disrupt a native metabolic pathway from dihydroxyacetone to glycerol. In certain aspects, the yeast cell is of the genera or . In other aspects, the yeast cell is capable of producing at least one organic acid, such as lactate. The yeast cells produce significantly less glycerol than the wild-type strains, and usually produce greater yields of desired fermentation products. Yeast cells of the invention often grow well when cultivated, despite their curtailed glycerol production.

A Fermentation Process Using Yeast Cells Having Disrupted Pathway From Dihydroxyacetone Phosphate To Glycerol

View page
US Patent:
20200377302, Dec 3, 2020
Filed:
Mar 30, 2018
Appl. No.:
15/941274
Inventors:
- Wayzata MN, US
Pirrko Suominen - Maple Grove MN, US
Aristos Aristidou - Excelsior MN, US
Brian J. Rush - Minneapolis MN, US
Kari Koivuranta - Helsinki, FI
Benjamin Matthew Hause - Currie MN, US
Thomas William McMullin - Minnetonka MN, US
Kevin Roberg-Perez - Minneapolis MN, US
Assignee:
Cargill Incorporated - Wayzata MN
International Classification:
B65G 15/12
B65G 17/12
E01B 29/32
Abstract:
Yeast cells are genetically modified to disrupt a native metabolic pathway from dihydroxyacetone to glycerol. In certain aspects, the yeast cell is of the genera or In other aspects, the yeast cell is capable of producing at least one organic acid, such as lactate. The yeast cells produce significantly less glycerol than the wild-type strains, and usually produce greater yields of desired fermentation products. Yeast cells of the invention often grow well when cultivated, despite their curtailed glycerol production.

Yeast Cells Having Disrupted Pathway From Dihydroxyacetone Phosphate To Glycerol

View page
US Patent:
20150315616, Nov 5, 2015
Filed:
May 25, 2015
Appl. No.:
14/720899
Inventors:
- Wayzata MN, US
Pirrko Suominen - Maple Grove MN, US
Aristos Aristidou - Excelsior MN, US
Brian J. Rush - Minneapolis MN, US
Kari Koivuranta - Helsinki, FI
Benjamin Matthew Hause - Currie MN, US
Thomas William McMullin - Minnetonka MN, US
Kevin Roberg-Perez - Minneapolis MN, US
International Classification:
C12P 7/56
C12P 7/40
C12P 7/06
Abstract:
Yeast cells are genetically modified to disrupt a native metabolic pathway from dihydroxyacetone to glycerol. In certain aspects, the yeast cell is of the genera or . In other aspects, the yeast cell is capable of producing at least one organic acid, such as lactate. The yeast cells produce significantly less glycerol than the wild-type strains, and usually produce greater yields of desired fermentation products. Yeast cells of the invention often grow well when cultivated, despite their curtailed glycerol production.
Control profile
Kevin J Roberg-Perez from Minneapolis, MN, age ~59 Get Report